Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition Unit | ASCAU | Sep 19, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Sep 19, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Sep 19, 2024 | 43.43 | +0.39 |
a.k.a Brands | AKA | Sep 19, 2024 | 25.00 | +1.87 |
A.O Smith | AOS | Sep 19, 2024 | 84.29 | +1.69 |
A10 Networks | ATEN | Sep 19, 2024 | 13.98 | +1.23 |
A2Z Smart Technologies | AZ | Sep 19, 2024 | 0.69 | +3.72 |
AAA - A Rated Corporate Bond Ishares | QLTA | Sep 19, 2024 | 49.27 | +0.08 |
Aadi Bioscience | AADI | Sep 19, 2024 | 1.83 | -2.14 |
AAON | AAON | Sep 19, 2024 | 102.45 | +5.69 |
AAR | AIR | Sep 19, 2024 | 69.55 | +0.96 |
Abacus Life | ABL | Sep 19, 2024 | 9.89 | -4.90 |
Abbott Laboratories | ABT | Sep 19, 2024 | 114.15 | -0.64 |
AbbVie | ABBV | Sep 19, 2024 | 193.62 | +0.35 |
AbCellera Biologics | ABCL | Sep 19, 2024 | 2.74 | -0.36 |
Abeona Therapeutics | ABEO | Sep 19, 2024 | 5.80 | +6.42 |
Abercrombie & Fitch | ANF | Sep 19, 2024 | 139.32 | +2.86 |
Aberdeen Asia-Pacificome Fund | FAX | Sep 19, 2024 | 17.46 | +0.69 |
Aberdeen Australia Equity Fund | IAF | Sep 19, 2024 | 4.68 | +2.41 |
Aberdeen Emerging Markets Fund | AEF | Sep 19, 2024 | 5.46 | +2.25 |
Aberdeen Global Fund | FCO | Sep 19, 2024 | 5.96 | +1.02 |
Aberdeen Global Infrastructure | ASGI | Sep 19, 2024 | 19.91 | -0.25 |
Aberdeen Income Credit Strategies Fund | ACP | Sep 19, 2024 | 6.56 | +0.31 |
Aberdeen Income Credit Strategies Pref | ACP-A | Sep 19, 2024 | 24.31 | -0.57 |
Aberdeen Japan Equity Fund | JEQ | Sep 19, 2024 | 6.17 | +2.15 |
Abits Group | ABTS | Sep 19, 2024 | 0.52 | -2.39 |
Abivax SA - American Depositary Shares | ABVX | Sep 19, 2024 | 11.55 | +1.58 |
Able View Global | ABLV | Sep 19, 2024 | 0.93 | -4.26 |
ABM Industries | ABM | Sep 19, 2024 | 51.83 | +1.75 |
Above Food Ingredients | ABVE | Sep 19, 2024 | 0.58 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.